Inventor · disambiguated record
Yen-Wah Lee
Also filed as: LEE YEN-WAH · LEE YEN-WAH ROZANNE
6 granted patents·4 pending applications·109 citations·filing 2003–2021
80Inventor score
Top patents by PatentIndex Score
10 records- 0195US7285269B2Antibodies directed to tumor necrosis factorAMGEN FREMONT INC·Filed 2003·Granted Oct 23, 2007·101 cites·35 claims
- 0281US11016099B2Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkersAMGEN INC·Filed 2016·Granted May 25, 2021·3 cites·22 claims
- 0377US11220541B2CCL20 as a predictor of clinical response to IL23-antagonistsAMGEN INC·Filed 2016·Granted Jan 11, 2022·1 cites·32 claims
- 0474US8101178B2Antibodies directed to tumor necrosis factor and uses thereofBABCOOK JOHN S·Filed 2007·Granted Jan 24, 2012·3 cites·21 claims
- 0570US10775388B2Methods of using antibodies to determine periostin levels in a sampleMEDIMMUNE LLC·Filed 2015·Granted Sep 15, 2020·1 cites·23 claims
- 0663US2022144935A1Ccl20 as a predictor of clinical response to il23-antagonistsAMGEN INC·Filed 2021·Application pending·0 cites
- 0755US9862762B2Monoclonal antibodies which bind human periostinMEDIMMUNE LLC·Filed 2015·Granted Jan 9, 2018·0 cites·18 claims
- 0855US2018179272A1Novel assay to detect human periostinMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 0953US2022373539A1Prediction of clinical response to il23-antagonists using il23 pathway biomarkersAMGEN INC·Filed 2021·Application pending·0 cites
- 1044US2005058649A1Antibodies directed to phospholipase A2 and uses thereofFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →